3rd Osteoarthritis Patients Pre-Congress 2021

On Wednesday 13th, October 2021, the third edition of the OAFI Foundation Precongress took place, bringing together representatives of institutions such as the European Medicines Agency (EMA), the AEMPS and the FDA, together with editors of leading medical journals (The Lancet or BMC Musculoskeletal Disorders), as well as prestigious researchers and representatives of international patients associations.

This annual scientific-medical meeting aims to create actions aimed at improving the quality of life of patients, promoting a favorable environment for R&D and the development of new treatments.

Find all the conferences below!

1. Welcome Remarks

Speaker:

• Dr Josep Vergés, President & CEO of OAFI Foundation (Spain)

2. Patients and Public Involvement (PPI) in the peer-review publication process

Moderator: Dr. Xavier Carné, Clinical Pharmacologist

Speakers:

• Dr. Ciaran Fitzpatrick, Editor BMC Musculoskeletal Disorders (UK)

• Dr. Mabel Chew, Editor The Lancet, Sydney, Australia (MC), Lancet commissions and PPI

• Professor David Hunter, Florance and Cope Chair of Rheumatology at University of Sydney (Australia)

3. Pre & Clinical Research with OA Patients after COVID

Moderator: Dr. Xavier Carné, Clinical Pharmacologist

Speakers:

• Prof. Ali Mobasheri, President of OARSI

• Prof. Leigh F. Callahan, Director of Osteoarthritis Action Alliance (OAAA)

• Ms Aina Pascual, Science, Research & Innovation at OAFI Foundation

4. How the regulatory agency engages with patients

Moderator: Dr. Xavier Carné, Clinical Pharmacologist

Speakers:

• Ms Nathalie Bere, Patient engagement, European Medicines Agency (EMA)

• Ms Anna Hyde, Vice President of Advocacy and Access and FDA Affairs, Arthitis Foundation (AF)

• Dr. César Hernández, Head Drugs for Human Use (Spanish Drug Agency (AEMPS)

5. The OA Patients Task Force

Moderator: Dr. Xavier Carné, Clinical Pharmacologist

Introduction to session: Dr. Josep Vergés, President & CEO OAFI Foundation

Speakers:

• Ms Anna Hyde, Vice President of Advocacy and Access and FDA Affairs, Arthitis Foundation (AF)

• Ms Claude Jandard, Association Française de Lutte Anti- Rhumatismale (AFLAR)

• Mr Andrea Tomasini, Associazione Nazionale Persona con Malattie Reumatologiche e Rare (APMARR)

6. Conclusions and closing of the day

Speakers:

• Dr. Xavier Carné, Clinical Pharmacologist

• Dr. Josep Vergés, President & CEO, OAFI Foundation

PRONTO TODOS LOS VIDEOS DEL #OAFICONGRESS19